These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10815679)
1. Iatrogenic arterial spasm relieved by intraarterial mannitol infusion. Fortin D; Osztie E; Neuwelt EA AJNR Am J Neuroradiol; 2000 May; 21(5):968-70. PubMed ID: 10815679 [TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier disruption for the treatment of malignant brain tumors: The National Program. Doolittle ND; Petrillo A; Bell S; Cummings P; Eriksen S J Neurosci Nurs; 1998 Apr; 30(2):81-90. PubMed ID: 9642616 [TBL] [Abstract][Full Text] [Related]
3. Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption. Bonstelle CT; Kori SH; Rekate H AJNR Am J Neuroradiol; 1983; 4(3):810-2. PubMed ID: 6410860 [TBL] [Abstract][Full Text] [Related]
4. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]. Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082 [TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648 [TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption]. Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817 [TBL] [Abstract][Full Text] [Related]
7. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316 [TBL] [Abstract][Full Text] [Related]
8. Durability of single dose intra-arterial bevacizumab after blood/brain barrier disruption for recurrent glioblastoma. Chakraborty S; Filippi CG; Burkhardt JK; Fralin S; Ray A; Wong T; Ortiz R; Langer DJ; Boockvar JA J Exp Ther Oncol; 2016 Nov; 11(4):261-267. PubMed ID: 27849336 [TBL] [Abstract][Full Text] [Related]
9. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol]. Miyagami M; Kagawa Y; Tsubokawa T No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632 [TBL] [Abstract][Full Text] [Related]
10. [Intra-arterial ACNU, CDDP chemotherapy for brain metastases from lung cancer: comparison of cases with and without intra-arterial mannitol infusion]. Iwadate Y; Namba H; Saegusa T; Sueyoshi K No Shinkei Geka; 1993 Jun; 21(6):513-8. PubMed ID: 8336809 [TBL] [Abstract][Full Text] [Related]
11. Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going. D'Amico RS; Khatri D; Reichman N; Patel NV; Wong T; Fralin SR; Li M; Ellis JA; Ortiz R; Langer DJ; Boockvar JA J Neurooncol; 2020 Apr; 147(2):261-278. PubMed ID: 32076934 [TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma. Hill SA; Neuwelt EA J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704 [No Abstract] [Full Text] [Related]